nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR6—Raloxifene—osteoporosis	0.16	0.282	CbGbCtD
Asenapine—HTR2B—Raloxifene—osteoporosis	0.142	0.252	CbGbCtD
Asenapine—CYP1A2—Estropipate—osteoporosis	0.0506	0.0895	CbGbCtD
Asenapine—CYP3A4—Estropipate—osteoporosis	0.0265	0.0469	CbGbCtD
Asenapine—CYP3A4—Calcitriol—osteoporosis	0.0265	0.0469	CbGbCtD
Asenapine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0239	0.0423	CbGbCtD
Asenapine—CYP2D6—Cholecalciferol—osteoporosis	0.0215	0.038	CbGbCtD
Asenapine—CYP3A4—Ergocalciferol—osteoporosis	0.0212	0.0375	CbGbCtD
Asenapine—CYP1A2—Estradiol—osteoporosis	0.021	0.0372	CbGbCtD
Asenapine—CYP3A4—Raloxifene—osteoporosis	0.0177	0.0313	CbGbCtD
Asenapine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0171	0.0302	CbGbCtD
Asenapine—CYP3A4—Cholecalciferol—osteoporosis	0.0136	0.0242	CbGbCtD
Asenapine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0125	0.0222	CbGbCtD
Asenapine—CYP3A4—Estradiol—osteoporosis	0.011	0.0195	CbGbCtD
Asenapine—Immune system disorder—Zoledronate—osteoporosis	0.000458	0.00158	CcSEcCtD
Asenapine—Mediastinal disorder—Zoledronate—osteoporosis	0.000457	0.00158	CcSEcCtD
Asenapine—Eye disorder—Conjugated Estrogens—osteoporosis	0.000456	0.00157	CcSEcCtD
Asenapine—Syncope—Risedronate—osteoporosis	0.000456	0.00157	CcSEcCtD
Asenapine—Insomnia—Ibandronate—osteoporosis	0.000455	0.00157	CcSEcCtD
Asenapine—Dyspepsia—Alendronate—osteoporosis	0.000455	0.00157	CcSEcCtD
Asenapine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000453	0.00156	CcSEcCtD
Asenapine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000453	0.00156	CcSEcCtD
Asenapine—Fatigue—Estropipate—osteoporosis	0.000452	0.00156	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000449	0.00155	CcSEcCtD
Asenapine—Constipation—Estropipate—osteoporosis	0.000449	0.00155	CcSEcCtD
Asenapine—Dyspepsia—Raloxifene—osteoporosis	0.000448	0.00154	CcSEcCtD
Asenapine—Hypersensitivity—Etidronic acid—osteoporosis	0.000447	0.00154	CcSEcCtD
Asenapine—Loss of consciousness—Risedronate—osteoporosis	0.000447	0.00154	CcSEcCtD
Asenapine—Anaemia—Pamidronate—osteoporosis	0.000447	0.00154	CcSEcCtD
Asenapine—Insomnia—Calcitriol—osteoporosis	0.000446	0.00154	CcSEcCtD
Asenapine—Weight increased—Estradiol—osteoporosis	0.000444	0.00153	CcSEcCtD
Asenapine—Mental disorder—Zoledronate—osteoporosis	0.000444	0.00153	CcSEcCtD
Asenapine—Agitation—Pamidronate—osteoporosis	0.000444	0.00153	CcSEcCtD
Asenapine—Dyspepsia—Ibandronate—osteoporosis	0.000443	0.00153	CcSEcCtD
Asenapine—Angiopathy—Conjugated Estrogens—osteoporosis	0.000443	0.00153	CcSEcCtD
Asenapine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000442	0.00153	CcSEcCtD
Asenapine—Constipation—Alendronate—osteoporosis	0.000442	0.00153	CcSEcCtD
Asenapine—Angioedema—Pamidronate—osteoporosis	0.000441	0.00152	CcSEcCtD
Asenapine—Malnutrition—Zoledronate—osteoporosis	0.000441	0.00152	CcSEcCtD
Asenapine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000441	0.00152	CcSEcCtD
Asenapine—Hyperglycaemia—Estradiol—osteoporosis	0.00044	0.00152	CcSEcCtD
Asenapine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00044	0.00152	CcSEcCtD
Asenapine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000439	0.00151	CcSEcCtD
Asenapine—Hypertension—Risedronate—osteoporosis	0.000439	0.00151	CcSEcCtD
Asenapine—Somnolence—Calcitriol—osteoporosis	0.000438	0.00151	CcSEcCtD
Asenapine—Malaise—Pamidronate—osteoporosis	0.000436	0.0015	CcSEcCtD
Asenapine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000435	0.0015	CcSEcCtD
Asenapine—Depression—Estradiol—osteoporosis	0.000434	0.0015	CcSEcCtD
Asenapine—Fatigue—Ibandronate—osteoporosis	0.000434	0.0015	CcSEcCtD
Asenapine—Syncope—Pamidronate—osteoporosis	0.000433	0.00149	CcSEcCtD
Asenapine—Arthralgia—Risedronate—osteoporosis	0.000433	0.00149	CcSEcCtD
Asenapine—Leukopenia—Pamidronate—osteoporosis	0.000432	0.00149	CcSEcCtD
Asenapine—Dysgeusia—Zoledronate—osteoporosis	0.000432	0.00149	CcSEcCtD
Asenapine—Anxiety—Risedronate—osteoporosis	0.000431	0.00149	CcSEcCtD
Asenapine—Constipation—Ibandronate—osteoporosis	0.00043	0.00148	CcSEcCtD
Asenapine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000428	0.00148	CcSEcCtD
Asenapine—Malnutrition—Conjugated Estrogens—osteoporosis	0.000425	0.00147	CcSEcCtD
Asenapine—Loss of consciousness—Pamidronate—osteoporosis	0.000425	0.00146	CcSEcCtD
Asenapine—Muscle spasms—Zoledronate—osteoporosis	0.000424	0.00146	CcSEcCtD
Asenapine—Dry mouth—Risedronate—osteoporosis	0.000423	0.00146	CcSEcCtD
Asenapine—Constipation—Calcitriol—osteoporosis	0.000421	0.00145	CcSEcCtD
Asenapine—Convulsion—Pamidronate—osteoporosis	0.000419	0.00144	CcSEcCtD
Asenapine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000417	0.00144	CcSEcCtD
Asenapine—Hypertension—Pamidronate—osteoporosis	0.000417	0.00144	CcSEcCtD
Asenapine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000416	0.00144	CcSEcCtD
Asenapine—Tremor—Zoledronate—osteoporosis	0.000413	0.00143	CcSEcCtD
Asenapine—Hepatobiliary disease—Estradiol—osteoporosis	0.000412	0.00142	CcSEcCtD
Asenapine—Arthralgia—Pamidronate—osteoporosis	0.000411	0.00142	CcSEcCtD
Asenapine—Anxiety—Pamidronate—osteoporosis	0.00041	0.00141	CcSEcCtD
Asenapine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000409	0.00141	CcSEcCtD
Asenapine—Shock—Risedronate—osteoporosis	0.000408	0.00141	CcSEcCtD
Asenapine—Anaemia—Zoledronate—osteoporosis	0.000408	0.00141	CcSEcCtD
Asenapine—Nervous system disorder—Risedronate—osteoporosis	0.000407	0.0014	CcSEcCtD
Asenapine—Agitation—Zoledronate—osteoporosis	0.000406	0.0014	CcSEcCtD
Asenapine—Angioedema—Zoledronate—osteoporosis	0.000403	0.00139	CcSEcCtD
Asenapine—Malaise—Zoledronate—osteoporosis	0.000398	0.00137	CcSEcCtD
Asenapine—Syncope—Zoledronate—osteoporosis	0.000396	0.00137	CcSEcCtD
Asenapine—Leukopenia—Zoledronate—osteoporosis	0.000395	0.00136	CcSEcCtD
Asenapine—Anaphylactic shock—Pamidronate—osteoporosis	0.000394	0.00136	CcSEcCtD
Asenapine—Angioedema—Conjugated Estrogens—osteoporosis	0.000388	0.00134	CcSEcCtD
Asenapine—Shock—Pamidronate—osteoporosis	0.000388	0.00134	CcSEcCtD
Asenapine—Loss of consciousness—Zoledronate—osteoporosis	0.000388	0.00134	CcSEcCtD
Asenapine—Hypersensitivity—Estropipate—osteoporosis	0.000387	0.00133	CcSEcCtD
Asenapine—Nervous system disorder—Pamidronate—osteoporosis	0.000387	0.00133	CcSEcCtD
Asenapine—Thrombocytopenia—Pamidronate—osteoporosis	0.000386	0.00133	CcSEcCtD
Asenapine—Vomiting—Etidronic acid—osteoporosis	0.000386	0.00133	CcSEcCtD
Asenapine—Oedema peripheral—Estradiol—osteoporosis	0.000385	0.00133	CcSEcCtD
Asenapine—Tachycardia—Pamidronate—osteoporosis	0.000385	0.00133	CcSEcCtD
Asenapine—Connective tissue disorder—Estradiol—osteoporosis	0.000384	0.00132	CcSEcCtD
Asenapine—Rash—Etidronic acid—osteoporosis	0.000383	0.00132	CcSEcCtD
Asenapine—Convulsion—Zoledronate—osteoporosis	0.000382	0.00132	CcSEcCtD
Asenapine—Dermatitis—Etidronic acid—osteoporosis	0.000382	0.00132	CcSEcCtD
Asenapine—Syncope—Conjugated Estrogens—osteoporosis	0.000381	0.00131	CcSEcCtD
Asenapine—Hypertension—Zoledronate—osteoporosis	0.000381	0.00131	CcSEcCtD
Asenapine—Hypersensitivity—Alendronate—osteoporosis	0.000381	0.00131	CcSEcCtD
Asenapine—Headache—Etidronic acid—osteoporosis	0.00038	0.00131	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000378	0.0013	CcSEcCtD
Asenapine—Asthenia—Estropipate—osteoporosis	0.000377	0.0013	CcSEcCtD
Asenapine—Arthralgia—Zoledronate—osteoporosis	0.000376	0.0013	CcSEcCtD
Asenapine—Insomnia—Risedronate—osteoporosis	0.000375	0.00129	CcSEcCtD
Asenapine—Anxiety—Zoledronate—osteoporosis	0.000374	0.00129	CcSEcCtD
Asenapine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000373	0.00129	CcSEcCtD
Asenapine—Asthenia—Alendronate—osteoporosis	0.000371	0.00128	CcSEcCtD
Asenapine—Hypersensitivity—Ibandronate—osteoporosis	0.000371	0.00128	CcSEcCtD
Asenapine—Dyspnoea—Risedronate—osteoporosis	0.00037	0.00128	CcSEcCtD
Asenapine—Hypotension—Pamidronate—osteoporosis	0.000368	0.00127	CcSEcCtD
Asenapine—Convulsion—Conjugated Estrogens—osteoporosis	0.000368	0.00127	CcSEcCtD
Asenapine—Dry mouth—Zoledronate—osteoporosis	0.000367	0.00127	CcSEcCtD
Asenapine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000367	0.00127	CcSEcCtD
Asenapine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000367	0.00127	CcSEcCtD
Asenapine—Dyspepsia—Risedronate—osteoporosis	0.000365	0.00126	CcSEcCtD
Asenapine—Eye disorder—Estradiol—osteoporosis	0.000365	0.00126	CcSEcCtD
Asenapine—Constipation—Ethinyl Estradiol—osteoporosis	0.000364	0.00126	CcSEcCtD
Asenapine—Hypersensitivity—Calcitriol—osteoporosis	0.000363	0.00125	CcSEcCtD
Asenapine—Cardiac disorder—Estradiol—osteoporosis	0.000363	0.00125	CcSEcCtD
Asenapine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000362	0.00125	CcSEcCtD
Asenapine—Asthenia—Ibandronate—osteoporosis	0.000361	0.00125	CcSEcCtD
Asenapine—Anxiety—Conjugated Estrogens—osteoporosis	0.000361	0.00124	CcSEcCtD
Asenapine—Nausea—Etidronic acid—osteoporosis	0.00036	0.00124	CcSEcCtD
Asenapine—Anaphylactic shock—Zoledronate—osteoporosis	0.00036	0.00124	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000359	0.00124	CcSEcCtD
Asenapine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000358	0.00124	CcSEcCtD
Asenapine—Fatigue—Risedronate—osteoporosis	0.000358	0.00123	CcSEcCtD
Asenapine—Insomnia—Pamidronate—osteoporosis	0.000357	0.00123	CcSEcCtD
Asenapine—Constipation—Risedronate—osteoporosis	0.000355	0.00122	CcSEcCtD
Asenapine—Angiopathy—Estradiol—osteoporosis	0.000354	0.00122	CcSEcCtD
Asenapine—Shock—Zoledronate—osteoporosis	0.000354	0.00122	CcSEcCtD
Asenapine—Asthenia—Calcitriol—osteoporosis	0.000353	0.00122	CcSEcCtD
Asenapine—Nervous system disorder—Zoledronate—osteoporosis	0.000353	0.00122	CcSEcCtD
Asenapine—Immune system disorder—Estradiol—osteoporosis	0.000353	0.00122	CcSEcCtD
Asenapine—Thrombocytopenia—Zoledronate—osteoporosis	0.000353	0.00122	CcSEcCtD
Asenapine—Mediastinal disorder—Estradiol—osteoporosis	0.000352	0.00121	CcSEcCtD
Asenapine—Dyspnoea—Pamidronate—osteoporosis	0.000352	0.00121	CcSEcCtD
Asenapine—Tachycardia—Zoledronate—osteoporosis	0.000351	0.00121	CcSEcCtD
Asenapine—Somnolence—Pamidronate—osteoporosis	0.000351	0.00121	CcSEcCtD
Asenapine—Dyspepsia—Pamidronate—osteoporosis	0.000347	0.0012	CcSEcCtD
Asenapine—Dizziness—Estropipate—osteoporosis	0.000347	0.0012	CcSEcCtD
Asenapine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000347	0.0012	CcSEcCtD
Asenapine—Mental disorder—Estradiol—osteoporosis	0.000342	0.00118	CcSEcCtD
Asenapine—Dizziness—Alendronate—osteoporosis	0.000342	0.00118	CcSEcCtD
Asenapine—Shock—Conjugated Estrogens—osteoporosis	0.000341	0.00118	CcSEcCtD
Asenapine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00034	0.00117	CcSEcCtD
Asenapine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00034	0.00117	CcSEcCtD
Asenapine—Malnutrition—Estradiol—osteoporosis	0.00034	0.00117	CcSEcCtD
Asenapine—Fatigue—Pamidronate—osteoporosis	0.00034	0.00117	CcSEcCtD
Asenapine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000338	0.00117	CcSEcCtD
Asenapine—Constipation—Pamidronate—osteoporosis	0.000337	0.00116	CcSEcCtD
Asenapine—Hypotension—Zoledronate—osteoporosis	0.000337	0.00116	CcSEcCtD
Asenapine—Dizziness—Raloxifene—osteoporosis	0.000336	0.00116	CcSEcCtD
Asenapine—Vomiting—Estropipate—osteoporosis	0.000334	0.00115	CcSEcCtD
Asenapine—Dysgeusia—Estradiol—osteoporosis	0.000333	0.00115	CcSEcCtD
Asenapine—Dizziness—Ibandronate—osteoporosis	0.000333	0.00115	CcSEcCtD
Asenapine—Rash—Estropipate—osteoporosis	0.000331	0.00114	CcSEcCtD
Asenapine—Dermatitis—Estropipate—osteoporosis	0.000331	0.00114	CcSEcCtD
Asenapine—Headache—Estropipate—osteoporosis	0.000329	0.00113	CcSEcCtD
Asenapine—Vomiting—Alendronate—osteoporosis	0.000329	0.00113	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000328	0.00113	CcSEcCtD
Asenapine—Muscle spasms—Estradiol—osteoporosis	0.000327	0.00113	CcSEcCtD
Asenapine—Rash—Alendronate—osteoporosis	0.000326	0.00112	CcSEcCtD
Asenapine—Insomnia—Zoledronate—osteoporosis	0.000326	0.00112	CcSEcCtD
Asenapine—Dermatitis—Alendronate—osteoporosis	0.000326	0.00112	CcSEcCtD
Asenapine—Hypotension—Conjugated Estrogens—osteoporosis	0.000324	0.00112	CcSEcCtD
Asenapine—Headache—Alendronate—osteoporosis	0.000324	0.00112	CcSEcCtD
Asenapine—Vomiting—Raloxifene—osteoporosis	0.000323	0.00112	CcSEcCtD
Asenapine—Dyspnoea—Zoledronate—osteoporosis	0.000321	0.00111	CcSEcCtD
Asenapine—Rash—Raloxifene—osteoporosis	0.000321	0.00111	CcSEcCtD
Asenapine—Dermatitis—Raloxifene—osteoporosis	0.00032	0.0011	CcSEcCtD
Asenapine—Somnolence—Zoledronate—osteoporosis	0.00032	0.0011	CcSEcCtD
Asenapine—Vomiting—Ibandronate—osteoporosis	0.00032	0.0011	CcSEcCtD
Asenapine—Tremor—Estradiol—osteoporosis	0.000319	0.0011	CcSEcCtD
Asenapine—Headache—Raloxifene—osteoporosis	0.000318	0.0011	CcSEcCtD
Asenapine—Rash—Ibandronate—osteoporosis	0.000317	0.00109	CcSEcCtD
Asenapine—Dermatitis—Ibandronate—osteoporosis	0.000317	0.00109	CcSEcCtD
Asenapine—Dyspepsia—Zoledronate—osteoporosis	0.000317	0.00109	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000316	0.00109	CcSEcCtD
Asenapine—Headache—Ibandronate—osteoporosis	0.000315	0.00109	CcSEcCtD
Asenapine—Insomnia—Conjugated Estrogens—osteoporosis	0.000314	0.00108	CcSEcCtD
Asenapine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000313	0.00108	CcSEcCtD
Asenapine—Vomiting—Calcitriol—osteoporosis	0.000313	0.00108	CcSEcCtD
Asenapine—Agitation—Estradiol—osteoporosis	0.000313	0.00108	CcSEcCtD
Asenapine—Nausea—Estropipate—osteoporosis	0.000312	0.00108	CcSEcCtD
Asenapine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000311	0.00107	CcSEcCtD
Asenapine—Angioedema—Estradiol—osteoporosis	0.000311	0.00107	CcSEcCtD
Asenapine—Rash—Calcitriol—osteoporosis	0.000311	0.00107	CcSEcCtD
Asenapine—Fatigue—Zoledronate—osteoporosis	0.000311	0.00107	CcSEcCtD
Asenapine—Dermatitis—Calcitriol—osteoporosis	0.00031	0.00107	CcSEcCtD
Asenapine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000309	0.00107	CcSEcCtD
Asenapine—Headache—Calcitriol—osteoporosis	0.000309	0.00106	CcSEcCtD
Asenapine—Somnolence—Conjugated Estrogens—osteoporosis	0.000308	0.00106	CcSEcCtD
Asenapine—Constipation—Zoledronate—osteoporosis	0.000308	0.00106	CcSEcCtD
Asenapine—Nausea—Alendronate—osteoporosis	0.000307	0.00106	CcSEcCtD
Asenapine—Malaise—Estradiol—osteoporosis	0.000307	0.00106	CcSEcCtD
Asenapine—Hypersensitivity—Risedronate—osteoporosis	0.000306	0.00105	CcSEcCtD
Asenapine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000305	0.00105	CcSEcCtD
Asenapine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000305	0.00105	CcSEcCtD
Asenapine—Syncope—Estradiol—osteoporosis	0.000305	0.00105	CcSEcCtD
Asenapine—Nausea—Raloxifene—osteoporosis	0.000302	0.00104	CcSEcCtD
Asenapine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000299	0.00103	CcSEcCtD
Asenapine—Fatigue—Conjugated Estrogens—osteoporosis	0.000299	0.00103	CcSEcCtD
Asenapine—Nausea—Ibandronate—osteoporosis	0.000299	0.00103	CcSEcCtD
Asenapine—Loss of consciousness—Estradiol—osteoporosis	0.000299	0.00103	CcSEcCtD
Asenapine—Asthenia—Risedronate—osteoporosis	0.000298	0.00103	CcSEcCtD
Asenapine—Constipation—Conjugated Estrogens—osteoporosis	0.000297	0.00102	CcSEcCtD
Asenapine—Hypertension—Estradiol—osteoporosis	0.000294	0.00101	CcSEcCtD
Asenapine—Nausea—Calcitriol—osteoporosis	0.000293	0.00101	CcSEcCtD
Asenapine—Hypersensitivity—Pamidronate—osteoporosis	0.00029	0.001	CcSEcCtD
Asenapine—Arthralgia—Estradiol—osteoporosis	0.00029	0.000999	CcSEcCtD
Asenapine—Anxiety—Estradiol—osteoporosis	0.000289	0.000995	CcSEcCtD
Asenapine—Dry mouth—Estradiol—osteoporosis	0.000283	0.000977	CcSEcCtD
Asenapine—Asthenia—Pamidronate—osteoporosis	0.000283	0.000976	CcSEcCtD
Asenapine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000281	0.000971	CcSEcCtD
Asenapine—Anaphylactic shock—Estradiol—osteoporosis	0.000278	0.000958	CcSEcCtD
Asenapine—Dizziness—Risedronate—osteoporosis	0.000274	0.000946	CcSEcCtD
Asenapine—Shock—Estradiol—osteoporosis	0.000273	0.000942	CcSEcCtD
Asenapine—Nervous system disorder—Estradiol—osteoporosis	0.000272	0.000939	CcSEcCtD
Asenapine—Tachycardia—Estradiol—osteoporosis	0.000271	0.000935	CcSEcCtD
Asenapine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00027	0.000933	CcSEcCtD
Asenapine—Rash—Ethinyl Estradiol—osteoporosis	0.000268	0.000925	CcSEcCtD
Asenapine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000268	0.000925	CcSEcCtD
Asenapine—Headache—Ethinyl Estradiol—osteoporosis	0.000267	0.000919	CcSEcCtD
Asenapine—Hypersensitivity—Zoledronate—osteoporosis	0.000265	0.000915	CcSEcCtD
Asenapine—Vomiting—Risedronate—osteoporosis	0.000264	0.00091	CcSEcCtD
Asenapine—Rash—Risedronate—osteoporosis	0.000262	0.000902	CcSEcCtD
Asenapine—Dermatitis—Risedronate—osteoporosis	0.000261	0.000901	CcSEcCtD
Asenapine—Dizziness—Pamidronate—osteoporosis	0.000261	0.0009	CcSEcCtD
Asenapine—Headache—Risedronate—osteoporosis	0.00026	0.000896	CcSEcCtD
Asenapine—Asthenia—Zoledronate—osteoporosis	0.000258	0.000891	CcSEcCtD
Asenapine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000255	0.000881	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000253	0.000872	CcSEcCtD
Asenapine—Nausea—Ethinyl Estradiol—osteoporosis	0.000253	0.000872	CcSEcCtD
Asenapine—Insomnia—Estradiol—osteoporosis	0.000251	0.000866	CcSEcCtD
Asenapine—Vomiting—Pamidronate—osteoporosis	0.000251	0.000865	CcSEcCtD
Asenapine—Asthenia—Conjugated Estrogens—osteoporosis	0.000249	0.000858	CcSEcCtD
Asenapine—Rash—Pamidronate—osteoporosis	0.000249	0.000858	CcSEcCtD
Asenapine—Dermatitis—Pamidronate—osteoporosis	0.000248	0.000857	CcSEcCtD
Asenapine—Dyspnoea—Estradiol—osteoporosis	0.000247	0.000854	CcSEcCtD
Asenapine—Headache—Pamidronate—osteoporosis	0.000247	0.000852	CcSEcCtD
Asenapine—Somnolence—Estradiol—osteoporosis	0.000247	0.000851	CcSEcCtD
Asenapine—Nausea—Risedronate—osteoporosis	0.000246	0.00085	CcSEcCtD
Asenapine—Dyspepsia—Estradiol—osteoporosis	0.000244	0.000843	CcSEcCtD
Asenapine—Gastrointestinal disorder—Estradiol—osteoporosis	0.00024	0.000827	CcSEcCtD
Asenapine—Fatigue—Estradiol—osteoporosis	0.000239	0.000826	CcSEcCtD
Asenapine—Dizziness—Zoledronate—osteoporosis	0.000238	0.000822	CcSEcCtD
Asenapine—Constipation—Estradiol—osteoporosis	0.000237	0.000819	CcSEcCtD
Asenapine—Nausea—Pamidronate—osteoporosis	0.000234	0.000808	CcSEcCtD
Asenapine—Dizziness—Conjugated Estrogens—osteoporosis	0.000229	0.000791	CcSEcCtD
Asenapine—Vomiting—Zoledronate—osteoporosis	0.000229	0.00079	CcSEcCtD
Asenapine—Rash—Zoledronate—osteoporosis	0.000227	0.000783	CcSEcCtD
Asenapine—Dermatitis—Zoledronate—osteoporosis	0.000227	0.000783	CcSEcCtD
Asenapine—Headache—Zoledronate—osteoporosis	0.000226	0.000778	CcSEcCtD
Asenapine—Vomiting—Conjugated Estrogens—osteoporosis	0.00022	0.000761	CcSEcCtD
Asenapine—Rash—Conjugated Estrogens—osteoporosis	0.000219	0.000754	CcSEcCtD
Asenapine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000218	0.000754	CcSEcCtD
Asenapine—Headache—Conjugated Estrogens—osteoporosis	0.000217	0.00075	CcSEcCtD
Asenapine—Nausea—Zoledronate—osteoporosis	0.000214	0.000738	CcSEcCtD
Asenapine—Nausea—Conjugated Estrogens—osteoporosis	0.000206	0.000711	CcSEcCtD
Asenapine—Hypersensitivity—Estradiol—osteoporosis	0.000204	0.000705	CcSEcCtD
Asenapine—Asthenia—Estradiol—osteoporosis	0.000199	0.000687	CcSEcCtD
Asenapine—Dizziness—Estradiol—osteoporosis	0.000184	0.000633	CcSEcCtD
Asenapine—Vomiting—Estradiol—osteoporosis	0.000176	0.000609	CcSEcCtD
Asenapine—Rash—Estradiol—osteoporosis	0.000175	0.000604	CcSEcCtD
Asenapine—Dermatitis—Estradiol—osteoporosis	0.000175	0.000603	CcSEcCtD
Asenapine—Headache—Estradiol—osteoporosis	0.000174	0.0006	CcSEcCtD
Asenapine—Nausea—Estradiol—osteoporosis	0.000165	0.000569	CcSEcCtD
Asenapine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.36e-05	9.37e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—LEP—osteoporosis	1.35e-05	9.33e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.35e-05	9.32e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—POMC—osteoporosis	1.35e-05	9.31e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—POMC—osteoporosis	1.35e-05	9.3e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—IDH2—osteoporosis	1.35e-05	9.3e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.34e-05	9.27e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IRS1—osteoporosis	1.34e-05	9.24e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—POMC—osteoporosis	1.34e-05	9.24e-05	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.34e-05	9.21e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.34e-05	9.21e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—LEP—osteoporosis	1.34e-05	9.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.33e-05	9.17e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.32e-05	9.08e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6R—osteoporosis	1.32e-05	9.07e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.32e-05	9.07e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.31e-05	9.06e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—POMC—osteoporosis	1.31e-05	9.05e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.31e-05	9.02e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.31e-05	9.01e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.3e-05	8.95e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IGF1—osteoporosis	1.3e-05	8.94e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.3e-05	8.94e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—IL6—osteoporosis	1.3e-05	8.93e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—ESR1—osteoporosis	1.29e-05	8.91e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—POMC—osteoporosis	1.29e-05	8.9e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.29e-05	8.89e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.28e-05	8.82e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.28e-05	8.82e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.28e-05	8.81e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—ESR1—osteoporosis	1.27e-05	8.79e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ENO1—osteoporosis	1.27e-05	8.78e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GPX1—osteoporosis	1.27e-05	8.78e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.27e-05	8.77e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.27e-05	8.74e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.26e-05	8.7e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6R—osteoporosis	1.26e-05	8.68e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.26e-05	8.66e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.26e-05	8.66e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.24e-05	8.57e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IGF1—osteoporosis	1.24e-05	8.56e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ACP5—osteoporosis	1.23e-05	8.5e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—POMC—osteoporosis	1.23e-05	8.5e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.23e-05	8.49e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—LEP—osteoporosis	1.22e-05	8.39e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.22e-05	8.38e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IRS1—osteoporosis	1.21e-05	8.32e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.21e-05	8.31e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.2e-05	8.29e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.19e-05	8.23e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IRS1—osteoporosis	1.19e-05	8.21e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—LEP—osteoporosis	1.19e-05	8.2e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.19e-05	8.2e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.19e-05	8.17e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.18e-05	8.15e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.17e-05	8.1e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.17e-05	8.09e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.17e-05	8.08e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.16e-05	8.03e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.16e-05	8.02e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—POMC—osteoporosis	1.16e-05	8.01e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.16e-05	8.01e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.16e-05	7.98e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—POMC—osteoporosis	1.16e-05	7.97e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.15e-05	7.96e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.15e-05	7.93e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.15e-05	7.93e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.15e-05	7.92e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—POMC—osteoporosis	1.15e-05	7.91e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—TPI1—osteoporosis	1.15e-05	7.9e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—MYC—osteoporosis	1.14e-05	7.88e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TGFB1—osteoporosis	1.14e-05	7.86e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.14e-05	7.83e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.14e-05	7.83e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6R—osteoporosis	1.13e-05	7.82e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.13e-05	7.81e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.13e-05	7.76e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6R—osteoporosis	1.12e-05	7.71e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IGF1—osteoporosis	1.12e-05	7.71e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.11e-05	7.67e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.11e-05	7.66e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.11e-05	7.62e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IGF1—osteoporosis	1.1e-05	7.61e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.09e-05	7.48e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ENO1—osteoporosis	1.08e-05	7.44e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—P4HB—osteoporosis	1.08e-05	7.43e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.08e-05	7.41e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.08e-05	7.41e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.07e-05	7.36e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.06e-05	7.33e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.06e-05	7.33e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IRS1—osteoporosis	1.06e-05	7.32e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.06e-05	7.3e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—POMC—osteoporosis	1.05e-05	7.2e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.04e-05	7.2e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.04e-05	7.16e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.04e-05	7.14e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.03e-05	7.12e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.03e-05	7.12e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.03e-05	7.11e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.03e-05	7.08e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.03e-05	7.07e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—POMC—osteoporosis	1.02e-05	7.05e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—LEP—osteoporosis	1.02e-05	7.04e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.02e-05	7.03e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.02e-05	7.02e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—MYC—osteoporosis	1.02e-05	7.02e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TGFB1—osteoporosis	1.02e-05	7e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.01e-05	6.96e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.01e-05	6.93e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.01e-05	6.93e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.01e-05	6.93e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1e-05	6.92e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—LEP—osteoporosis	1e-05	6.91e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—POMC—osteoporosis	1e-05	6.89e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6R—osteoporosis	9.97e-06	6.87e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	9.96e-06	6.87e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—POMC—osteoporosis	9.94e-06	6.86e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—osteoporosis	9.93e-06	6.85e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—osteoporosis	9.92e-06	6.84e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—osteoporosis	9.86e-06	6.8e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.84e-06	6.79e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IGF1—osteoporosis	9.83e-06	6.78e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ESR1—osteoporosis	9.75e-06	6.72e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.75e-06	6.72e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6R—osteoporosis	9.7e-06	6.69e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—POMC—osteoporosis	9.67e-06	6.67e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—osteoporosis	9.65e-06	6.65e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.62e-06	6.63e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.6e-06	6.62e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ESR1—osteoporosis	9.58e-06	6.6e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IGF1—osteoporosis	9.57e-06	6.59e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—osteoporosis	9.5e-06	6.55e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	9.44e-06	6.5e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	9.4e-06	6.48e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—POMC—osteoporosis	9.4e-06	6.48e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	9.35e-06	6.44e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	9.3e-06	6.41e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—LEP—osteoporosis	9.15e-06	6.3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IRS1—osteoporosis	9.11e-06	6.28e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—osteoporosis	9.07e-06	6.25e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.97e-06	6.18e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IRS1—osteoporosis	8.95e-06	6.17e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.78e-06	6.05e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—POMC—osteoporosis	8.78e-06	6.05e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.73e-06	6.02e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—POMC—osteoporosis	8.64e-06	5.95e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.63e-06	5.95e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—POMC—osteoporosis	8.62e-06	5.94e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—osteoporosis	8.59e-06	5.92e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6R—osteoporosis	8.56e-06	5.9e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—osteoporosis	8.55e-06	5.89e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—POMC—osteoporosis	8.46e-06	5.83e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF1—osteoporosis	8.44e-06	5.82e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—osteoporosis	8.44e-06	5.82e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6R—osteoporosis	8.42e-06	5.81e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6R—osteoporosis	8.41e-06	5.79e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ENO1—osteoporosis	8.33e-06	5.74e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ADCY5—osteoporosis	8.32e-06	5.74e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF1—osteoporosis	8.31e-06	5.73e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GPX1—osteoporosis	8.3e-06	5.72e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF1—osteoporosis	8.29e-06	5.71e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	8.25e-06	5.69e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PSMA2—osteoporosis	8.21e-06	5.66e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PSMA5—osteoporosis	8.21e-06	5.66e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	8.16e-06	5.62e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	8.13e-06	5.61e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.86e-06	5.42e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MYC—osteoporosis	7.81e-06	5.38e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MYC—osteoporosis	7.8e-06	5.38e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.79e-06	5.37e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.78e-06	5.36e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MYC—osteoporosis	7.75e-06	5.34e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—osteoporosis	7.73e-06	5.33e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—osteoporosis	7.69e-06	5.3e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.66e-06	5.28e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MTHFR—osteoporosis	7.66e-06	5.28e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—osteoporosis	7.65e-06	5.27e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	7.62e-06	5.25e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MYC—osteoporosis	7.59e-06	5.23e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—osteoporosis	7.57e-06	5.22e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	7.56e-06	5.21e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—osteoporosis	7.52e-06	5.18e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MYC—osteoporosis	7.46e-06	5.15e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—osteoporosis	7.45e-06	5.13e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.35e-06	5.07e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—osteoporosis	7.32e-06	5.04e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MYC—osteoporosis	7.13e-06	4.91e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	7.12e-06	4.9e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	7.11e-06	4.9e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ADCY5—osteoporosis	7.05e-06	4.86e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—osteoporosis	7.03e-06	4.84e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MYC—osteoporosis	6.72e-06	4.63e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—osteoporosis	6.7e-06	4.62e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.66e-06	4.59e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MYC—osteoporosis	6.63e-06	4.57e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.61e-06	4.56e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—osteoporosis	6.49e-06	4.47e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—osteoporosis	6.46e-06	4.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.35e-06	4.38e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—osteoporosis	6.34e-06	4.37e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	6.22e-06	4.29e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—POMC—osteoporosis	6.12e-06	4.22e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MYC—osteoporosis	6.04e-06	4.16e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	6.03e-06	4.15e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MYC—osteoporosis	5.99e-06	4.13e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	5.97e-06	4.12e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MYC—osteoporosis	5.91e-06	4.07e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	5.9e-06	4.06e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—osteoporosis	5.87e-06	4.05e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—osteoporosis	5.86e-06	4.04e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—osteoporosis	5.82e-06	4.01e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.78e-06	3.98e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MYC—osteoporosis	5.78e-06	3.98e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.76e-06	3.97e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MYC—osteoporosis	5.75e-06	3.96e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.73e-06	3.95e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—osteoporosis	5.7e-06	3.93e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—osteoporosis	5.61e-06	3.87e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MYC—osteoporosis	5.59e-06	3.85e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	5.58e-06	3.85e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ADCY5—osteoporosis	5.44e-06	3.75e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—osteoporosis	5.42e-06	3.74e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—osteoporosis	5.36e-06	3.69e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—POMC—osteoporosis	5.19e-06	3.58e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MYC—osteoporosis	5.07e-06	3.5e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—osteoporosis	5.06e-06	3.49e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—osteoporosis	5.05e-06	3.48e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—osteoporosis	5.01e-06	3.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MYC—osteoporosis	4.99e-06	3.44e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—osteoporosis	4.98e-06	3.44e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MYC—osteoporosis	4.98e-06	3.43e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.98e-06	3.43e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.97e-06	3.43e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.89e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.88e-06	3.36e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.54e-06	3.13e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—osteoporosis	4.54e-06	3.13e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.53e-06	3.12e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—osteoporosis	4.5e-06	3.1e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—osteoporosis	4.44e-06	3.06e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—osteoporosis	4.34e-06	2.99e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—osteoporosis	4.32e-06	2.98e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—osteoporosis	4.2e-06	2.9e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—POMC—osteoporosis	4e-06	2.76e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—osteoporosis	3.81e-06	2.63e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—osteoporosis	3.75e-06	2.59e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—osteoporosis	3.74e-06	2.58e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.67e-06	2.53e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.41e-06	2.35e-05	CbGpPWpGaD
